Canopy Growth CEO Discusses Canadian Legalization, Beverage Deals

Marijuana stocks have experienced extreme volatility in recent weeks ahead of the Oct. 17 launch of the adult-use marijuana market in Canada. On Friday, Canopy Growth Corp CGC CEO Bruce Linton joined CNBC to discuss the growing global marijuana industry and the impact of Canadian legalization.

Beer Disruption

Earlier this month, Constellation Brands, Inc. STZ announced it would be making an additional $4 billion investment in Canopy as beer companies seek cannabis partners to potentially develop cannabis beverages. The news sent Canopy and other marijuana stocks soaring, and Linton said the entire cannabis group is rerating on the prospect of further beverage partnerships.

“It would be a pretty terrible job to be the CEO of a beer or spirits company and not have a cannabis strategy,” Linton said.

While the recent cannabis-related news has lifted most of the major stocks in the group, Linton said there will ultimately be only one or two companies which will rise to the top of the space.

“There is going to be a dominant leading company, and we are not that yet,” Linton said.

U.S. Off Limits

Linton said the Constellation cash is like rocket fuel for Canopy, which is working to expand its international business in 11 different countries where cannabis is federally legal. Canopy currently isn't operating in the U.S. market, where marijuana is still banned on a federal level.

“We have tried to lead the process of exiting [U.S.] prohibition so that we can be very disruptive to pharmaceutical, because there are a lot of ingredients that have not been harnessed under the last 95 years of prohibition,” Linton said.

Price Action

After a steep sell-off Thursday, U.S.-listed marijuana stocks reacted positively to the Linton interview on Friday:

  • Canopy Growth was up 2 percent.
  • Cronos Group Inc CRON was up 8 percent.
  • Tilray Inc TLRY was up 9 percent.

Related Links:

Cronos Group Plummets After Citron Calls It The 'Dark Side Of Cannabis'

Tilray's First Earnings Print Gives Cannabis Stocks Another Boost

Posted In: Bruce LintonCitron ResearchCannabisShort SellersTop StoriesMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.